The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction von Laeis, Petra, Püchler, Kurt, Kirch, Wilhelm

Volltext

Blood pressure response, but not adverse event incidence, correlates with dose of angiotensin II antagonist von Püchler, Kurt, Laeis, Petra, Stumpe, Klaus O

Volltext

Single dose and steady state pharmacokinetics of temocapril and temocaprilat in young and elderly hypertensive patients von Püchler, K., Sierakowski, B., Roots, I.

Volltext

Similarities and Differences between the United States and Europe in the Development of Fixed Combination Products for the Treatment of Hypertension von Alexander, John, Püchler, Kurt

Volltext

The effects of RS-8359 on cardiovascular function in healthy subjects and depressed patients von Plenker, Astrid, Püchler, Kurt, Volz, Hans-Peter

Volltext

Pharmacology of the new reversible inhibitor of monoamine oxidase A, RS-8359 von Iwata, Nobuyoshi, Püchler, Kurt, Plenker, Astrid

Volltext

THE EFFECT OF THE COMBINATION OF THE ORAL ANGIOTENSIN II-ANTAGONIST OLMESARTAN MEDOXOMIL AND GLIBENCLAMIDE ON PHARMACOKINETICS, SAFETY AND TOLERABILITY IN HEALTHY MALE SUBJECTS: P2... von Kreutz, R., Püchler, K., Laeis, P.

Volltext

Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients von Püchler, Kurt, Nussberger, Jürg, Laeis, Petra, Witte, Peter U, Brunner, Hans R

Volltext

Safety, tolerability and efficacy of the reversible monoamine oxidase inhibitor RS-8359 in early clinical trials von Püchler, Kurt, Plenker, Astrid, Volz, Hans-Peter

Volltext

The comparative effects of single and multiple doses of RS-8359, moclobemide and placebo on psychomotor function in healthy subjects von Püchler, Kurt, Schaffler, Klaus, Plenker, Astrid

Volltext

Value of Different Clinical and Biochemical Correlates to Assess Angiotensin Converting Enzyme Inhibition von Delacrétaz, Etienne, Nussberger, Jürg, Püchler, Kurt, Wood, Alan J, Robinson, Philip R, Waeber, Bernard, Brunner, Hans R

Volltext

COMBINATION THERAPY OF OLMESARTAN MEDOXOMIL WITH AMLODIPINE OR ATENOLOL MAINTAINS STEADY STATE PHARMACOKINETICS OF EACH DRUG UNCHANGED: P2.329 von Kreutz, R., Püchler, K., Laeis, P.

Volltext

Pharmacokinetics of temocapril and temocaprilat after 14 once daily oral doses of temocapril in hypertensive patients with varying degrees of renal impairment von Püchler, K., Eckl, K. M., Fritsche, L., Renneisen, K., Neumayer, H.‐H., Sierakowski, B., Lavrijssen, A. T. J., Thomsen, T., Roots, I.

Volltext

P.1.098 Early phase II results of the RIMA RS-8359 von Püchler, K., Plenker, A., Volz, H.-P.

Volltext

Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment von SIERAKOWSKI, B, PÜCHLER, K, WITTE, P. U, RENNEISEN, K, ROOTS, I

Volltext

The comparative effects of single and multiple doses of RS-8359, moclobemide and placebo on psychomotor function in healthy subjects: RS-8359, a putative candidate for the treatmen... von PÜCHLER, K, SCHAFFLER, K, PLENKER, A

Volltext

Safety, tolerability and efficacy of the reversible monoamine oxidase inhibitor RS-8359 in early clinical trials: RS-8359, a putative candidate for the treatment of depression von PÜCHLER, K, PLENKER, A, VOLZ, H.-P

Volltext

The effects of RS-8359 on cardiovascular function in healthy subjects and depressed patients: RS-8359, a putative candidate for the treatment of depression von PLENKER, A, PÜCHLER, K, VOLZ, H.-P

Volltext

Pharmacology of the new reversible inhibitor of monoamine oxidase A, RS-8359: RS-8359, a putative candidate for the treatment of depression von IWATA, N, PÜCHLER, K, PLENKER, A

Volltext

The pharmacokinetic profile of RS-8359 von Püchler, Kurt, Sasahara, Kunihiro, Plenker, Astrid, Nitanai, Takashi, Witte, Peter U

Volltext